Medical and Science
First female president of the Cardiac Society of Australia and New Zealand
The Cardiac Society of Australia and New Zealand (CSANZ) is pleased to announce the appointment of Professor Clara Chow as President-elect. Clara will be the CSANZ’s first female President, her term in office commencing in August 2020.
Clara Chow is Professor of the Faculty of Medicine and Health at the University of Sydney and is Academic Director of the Westmead Applied Medical Research Centre and Program Director Community Based Cardiac Services and Cardiologist at Westmead Hospital, Sydney.
The Cardiac Society of Australia and New Zealand is the professional body for cardiologists and those working in the area of cardiology including researchers, scientists, cardiovascular nurses, allied health professionals and other healthcare workers. The Society is established with the object of promoting the highest standards of education, training, research and practice in cardiovascular medicine and surgery as well as promoting the prevention and control of cardiovascular disease in human beings.
CSANZ President, Professor Len Kritharides, said “The CSANZ is very fortunate to have Clara as its incoming President. She is an outstanding Cardiologist and Researcher and will bring great energy and insight to the role.”
Professor Chow said “I am excited and proud to take up the President-elect position of the Cardiac Society of Australia and New Zealand. I think this shows the strong commitment of our society to change and addressing the challenges of diversity for our members as well as our patients.”
Prof Chow will serve as President-elect for 12 months and will take up the role of President in August, 2020.
You may also like Therapeutics and the importance of cancer research in Australia
News - Pharmaceuticals
New vaccine guidelines risk further decline in immunisation
The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]
MoreNews - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]
MoreNews - MedTech & Diagnostics
As insurer blame game escalates, patients miss out on the promise of private health
The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]
MoreLeadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
More